期刊
JOURNAL OF INFECTIOUS DISEASES
卷 221, 期 -, 页码 94-102出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiz638
关键词
acute respiratory distress syndrome; critical illness; Cytomegalovirus; sepsis
资金
- National Institutes of Health/National Institute of Allergy and Infectious Diseases [T32 AI118690-02, HHSN272201600016C, HHSN272201100041C, HHSN272201600019C]
Cytomegalovirus (CMV) reactivation has been described in adults with critical illness caused by diverse etiologies, especially severe sepsis, and observational studies have linked CMV reactivation with worse clinical outcomes in this setting. In this study, we review observational clinical data linking development of CMV reactivation with worse outcomes in patients in the intensive care unit, discuss potential biologically plausible mechanisms for a causal association, and summarize results of initial interventional trials that examined the effects of CMV prevention. These data, taken together, highlight the need for a randomized, placebo-controlled efficacy trial (1) to definitively determine whether prevention of CMV reactivation improves clinical outcomes of patients with critical illness and (2) to define the underlying mechanism(s).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据